ClinicalTrials.Veeva

Menu

Tritanium® Study in Japan

Stryker logo

Stryker

Status

Unknown

Conditions

Osteoarthritis
Avascular Necrosis of the Femoral Head
Rheumatoid Arthritis

Treatments

Device: Tritanium® cup

Study type

Observational

Funder types

Industry

Identifiers

NCT02552069
SJCR-OR-1505

Details and patient eligibility

About

The purpose of this study is to evaluate early fixation and stability of the Tritanium cup. It is expected that the Tritanium® cup will be equal to or better than conventional cementless cups in early fixation/stability and meet the expectations of Japanese surgeons.

Enrollment

50 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient is a candidate for a primary Total Hip Arthroplasty (THA).
  2. Patient who has diagnosis of secondary osteoarthritis, avascular necrosis and rheumatoid arthritis.
  3. Patient whose age is 20 or over.
  4. Patient who signed an Institutional Review Board (IRB)-approved, study specific Informed Patient Consent Form.
  5. Patient who is willing and able to comply with postoperative scheduled evaluations.

Exclusion criteria

  1. Patient who has a bacterial infectious disease or has a high risk of a bacterial infection.
  2. Patient who requires revision surgery of a previously implanted total hip arthroplasty.
  3. Patient who is morbidly obese, defined as having a Body Mass Index (BMI) > 40.
  4. Patient who is or may be pregnant female.
  5. Patient who has neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device.
  6. Patient with diagnosed systemic disease (i.e. Paget's disease, renal osteodystrophy), which limits ability to evaluate the safety and efficacy of the device.
  7. Patient who is immunologically suppressed or receiving chronic steroids, which limits ability to evaluate the safety and efficacy of the device.
  8. Patients who is judged ineligible with specific reason by primary doctor.

Trial design

50 participants in 1 patient group

Tritanium® cup
Treatment:
Device: Tritanium® cup

Trial contacts and locations

1

Loading...

Central trial contact

Ysuyuki Inatsugu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems